Reaction
Lipohypertrophy reporting signals
As of the last recalculation, Lipohypertrophy appears in 616 FAERS reports alongside 21 co-occurring drug terms. The strongest observed disproportionality signal is ASFOTASE ALFA (PRR 106.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Asfotase Alfa | 30 | 106.3 | 106.6 |
| Ritonavir | 55 | 69.7 | 69.9 |
| Darunavir | 26 | 60.6 | 60.7 |
| Ritonavir 100 Mg | 25 | 58.9 | 59.0 |
| Zidovudine | 20 | 52.2 | 52.3 |
| Lamivudine | 40 | 46.7 | 46.8 |
| Lopinavir And Ritonavir | 18 | 46.2 | 46.3 |
| Abacavir Sulfate | 13 | 46.0 | 46.1 |
| Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide | 13 | 44.6 | 44.6 |
| Raltegravir | 21 | 44.5 | 44.5 |
| Lamivudine Oral | 30 | 42.1 | 42.1 |
| Ciclesonide | 15 | 38.1 | 38.2 |
| Atazanavir | 14 | 33.7 | 33.7 |
| Itraconazole | 10 | 29.4 | 29.4 |
| Tenofovir Disoproxil Fumarate Tablets | 7 | 27.7 | 27.7 |
| Efavirenz | 9 | 27.7 | 27.7 |
| Insulin Glargine-Yfgn | 13 | 20.5 | 20.5 |
| Nevirapine | 5 | 18.9 | 18.9 |
| Emtricitabine And Tenofovir Disoproxil Fumarate | 24 | 18.5 | 18.5 |
| Voclosporin | 4 | 15.7 | 15.7 |
| Tenofovir Disoproxil Fumarate | 10 | 10.4 | 10.4 |